Results 261 to 270 of about 86,630 (338)

Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents. [PDF]

Geriatr Gerontol Int, 2019
Abe H, Shikuma J, Suwanai H, Sano K, Okumura T, Kan K, Takahashi T, Miwa T, Suzuki R, Odawara M.   +9 more
europepmc   +1 more source

Characteristics of type 1 diabetes in Northwest China: A multicenter hospital‐based study

Journal of Diabetes Investigation, EarlyView.
This study provided an overview of the characteristics of type 1 diabetes patients in Northwest China, a region with low incidence and limited healthcare resources, highlighting the necessity of enhancing public awareness and long‐term disease education and management. ABSTRACT Objective To comprehensively analyze the characteristics of type 1 diabetes
Yue Zhang, Xiaoning Liu, Xueni Yang, Yujie Zhang, Mengmeng Shang, Limin Tian   +5 more
wiley   +1 more source

Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: A retrospective cohort study. [PDF]

Pharmacol Res Perspect, 2019
Akimoto H, Tezuka K, Nishida Y, Nakayama T, Takahashi Y, Asai S.   +5 more
europepmc   +1 more source

Effect of a New Hypoglycemic Agent, A-4166 ((-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine), on Postprandial Blood Glucose Excursion: Comparison with Voglibose and Glibenclamide.

, 1997
Takao Ikenoue, Kouichirou Okazaki, Shoji Fujitani, Y Tsuchiya, Megumi Akiyoshi, Toshio Maki, Nobuo Kondo   +6 more
openalex   +2 more sources

BALLAST study: A multicentre, open‐label, randomized‐controlled, 52‐week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine‐enriched amino acid supplementation and physical exercise programme

Diabetes, Obesity and Metabolism, EarlyView.
Yoshihiro Takahashi, Makoto Hayashi, Takehiro Kato, Yukio Horikawa, Shin Tsunekawa, Hitoshi Kuwata, Yutaka Seino, Ryota Ogata, Kenta Murotani, Daisuke Yabe, BALLAST Study Group, Takehiro Kato, Makoto Hayashi, Hisashi Daido, Kouji Yamada, Takeshi Shimada, Kazuhisa Takami, Akihiko Sasaki, Toshiro Shibata, Shin‐ichi Kawachi, Nobutoshi Fushimi, Hiroyuki Niwa, Tomiko Horiya, Kijyun Nagata, Shun Ito   +24 more
wiley   +1 more source

Effects of short‐term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP‐ELM study

Journal of Diabetes Investigation, EarlyView.
Tofogliflozin was compared with metformin in treatment‐naïve people with type 2 diabetes for 4 weeks. Overall insulin secretory capacity did not improve; however, tofogliflozin was associated with an improved disposition index in individuals with poorer baseline glucose tolerance or greater improvement after treatment.
Maiko Miyamoto, Aika Miya, Akinobu Nakamura, Yuka Takahashi, Yuki Yamauchi, Shingo Yanagiya, Takahiro Takase, Mayuko Ono, Kiyohiko Takahashi, Kazufumi Okada, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, on behalf of TOP‐ELM study group, Maiko Miyamoto, Aika Miya, Akinobu Nakamura, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Kazufumi Okada, Rimi Izumihara, Yuki Oe, Takahiro Takase, So Nagai, Akihiro Takahashi, Yuka Takahashi, Yuki Yamauchi, Hiromichi Kijima, Shinji Taneda, Jun Takeuchi, Kei Yokozeki, Saki Kuwabara, Yoshiaki Arimura, Shinichiro Kawata, Tomonori Sekizaki, Yuki Yamauchi, Shingo Yanagiya, Mayuko Ono, Kiyohiko Takahashi   +39 more
wiley   +1 more source

Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis. [PDF]

Medicine (Baltimore), 2018
Xin WX, Fang L, Fang QL, Zheng XW, Ding HY, Huang P.   +5 more
europepmc   +1 more source

A new oral hypoglycemic agent, A-4166 [N-(trans-4-Isopropylcyclohexyl)-D-phenylalanine]

, 1989
Yoshiko Seto, Katsuaki Dan, Mariko Fukuma   +2 more
openalex   +1 more source

Increase in soluble RAGE following intensive insulin therapy is associated with β‐cell functional improvement and glycemic remission in newly diagnosed type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
Short‐term intensive insulin therapy (SIIT) markedly increased circulating sRAGE levels in newly diagnosed type 2 diabetes. The magnitude of sRAGE elevation was associated with improved β‐cell function and a higher likelihood of short‐term glycemic remission.
Qimou Chen, Fang Wei, Jiajing Ma, Xuhui Li, Boyuan Liu, Yanbing Li   +5 more
wiley   +1 more source

Synthesis and Inhibitory Effect of Some Indole-Pyrimidine Based Hybrid Heterocycles on α-Glucosidase and α-Amylase as Potential Hypoglycemic Agents. [PDF]

ChemistryOpen, 2019
Badria FA, Atef S, Al-Majid AM, Ali M, Elshaier YAMM, Ghabbour HA, Islam MS, Barakat A.   +7 more
europepmc   +1 more source